Kura Oncology KURA EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's EBIT?
- Kura Oncology (KURA) reported EBIT of -$78.82M in Q1 2026.
- How has Kura Oncology's EBIT changed year-over-year?
- Kura Oncology's EBIT decreased by 21.8% year-over-year, from -$64.7M to -$78.82M.
- What is the long-term trend for Kura Oncology's EBIT?
- Over 3 years (2022 to 2025), Kura Oncology's EBIT has grown at a 29.5% compound annual growth rate (CAGR), from -$139.87M to -$303.63M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.